TELA Bio CEO and leadership

Antony Koblish is currently CEO and President of TELA Bio, a surgical reconstruction company he co-founded in 2012. Prior to TELA, he served as the Chief Executive Officer and President at Orthovita, a manufacturer of biologics for spinal surgery. Before his eleven-year tenure at Orthovita, where he was promoted to Chief Executive from Director of Worldwide Marketing, Antony served as Director of Marketing and Product Development in the Reconstructive Specialty Group at Howmedica. He currently serves as a Director of CeraPedics, Orthobond and The Pennsylvania Biotechnology Association.Antony has a B.S. in Mechanical Engineering from Worcester Polytechnic Institute and a M.S. in Engineering, Mechanical Engineering and Applied Mechanics from the University of Pennsylvania.

Maarten Persenaire is a medical professional with 35 years of experience. Prior to founding TELA Bio, Dr. Persenaire was Chief Medical Officer at Orthovita, Inc. from 1999 to 2011. At Orthovita, Dr. Persenaire designed, managed, analyzed and filed an FDA-IDE study in vertebral fractures; managed post-market studies and data collection efforts in the areas of spine, orthopedics and trauma; and lectured on subjects such as bone biology and spinal fusions. Fluent in four languages, Dr. Persenaire received his medical degree at Groningen University in The Netherlands.

E Skott Greenhalgh are a Chief Technology Officer at TELA BIO, INC.. They have worked as VP:Research & Development at TELA BIO, INC. and Chief Technology Officer at US BioDesign. E studied at NC State University and Drexel University.

Peter Murphy is a Chief Commercial Officer at TELA BIO, INC.. He has worked as VP:Sales at Pacira Pharmaceuticals, Inc..

Antony Koblish is currently CEO and President of TELA Bio, a surgical reconstruction company he co-founded in 2012. Prior to TELA, he served as the Chief Executive Officer and President at Orthovita, a manufacturer of biologics for spinal surgery. Before his eleven-year tenure at Orthovita, where he was promoted to Chief Executive from Director of Worldwide Marketing, Antony served as Director of Marketing and Product Development in the Reconstructive Specialty Group at Howmedica. He currently serves as a Director of CeraPedics, Orthobond and The Pennsylvania Biotechnology Association.Antony has a B.S. in Mechanical Engineering from Worcester Polytechnic Institute and a M.S. in Engineering, Mechanical Engineering and Applied Mechanics from the University of Pennsylvania.

Maarten Persenaire is a medical professional with 35 years of experience. Prior to founding TELA Bio, Dr. Persenaire was Chief Medical Officer at Orthovita, Inc. from 1999 to 2011. At Orthovita, Dr. Persenaire designed, managed, analyzed and filed an FDA-IDE study in vertebral fractures; managed post-market studies and data collection efforts in the areas of spine, orthopedics and trauma; and lectured on subjects such as bone biology and spinal fusions. Fluent in four languages, Dr. Persenaire received his medical degree at Groningen University in The Netherlands.

Antony Koblish is currently CEO and President of TELA Bio, a surgical reconstruction company he co-founded in 2012. Prior to TELA, he served as the Chief Executive Officer and President at Orthovita, a manufacturer of biologics for spinal surgery. Before his eleven-year tenure at Orthovita, where he was promoted to Chief Executive from Director of Worldwide Marketing, Antony served as Director of Marketing and Product Development in the Reconstructive Specialty Group at Howmedica. He currently serves as a Director of CeraPedics, Orthobond and The Pennsylvania Biotechnology Association.Antony has a B.S. in Mechanical Engineering from Worcester Polytechnic Institute and a M.S. in Engineering, Mechanical Engineering and Applied Mechanics from the University of Pennsylvania.